SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-071261
Filing Date
2024-06-13
Accepted
2024-06-13 16:09:21
Documents
13
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2417208d1_8k.htm   iXBRL 8-K 27398
  Complete submission text file 0001104659-24-071261.txt   200588

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nvct-20240613.xsd EX-101.SCH 3015
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvct-20240613_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvct-20240613_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2417208d1_8k_htm.xml XML 3652
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41264 | Film No.: 241041300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)